198 related articles for article (PubMed ID: 27410928)
41. Comparison of ondansetron-dexamethasone-lorazepam versus metoclopramide-dexamethasone-lorazepam in the control of cisplatin induced emesis.
Manusirivithaya S; Chareoniam V; Isariyodom P; Sungsab D
J Med Assoc Thai; 2001 Jul; 84(7):966-72. PubMed ID: 11759977
[TBL] [Abstract][Full Text] [Related]
42. Clinical evaluation of two antiemetic combinations palonosetron dexamethasone versus ondansetron dexamethasone in chemotherapy of head and neck cancer.
Kaushal J; Gupta MC; Kaushal V; Bhutani G; Dhankar R; Atri R; Verma S
Singapore Med J; 2010 Nov; 51(11):871-5. PubMed ID: 21140114
[TBL] [Abstract][Full Text] [Related]
43. Prevention of cisplatin-induced delayed emesis: still unsatisfactory. Italian Group for Antiemetic Research.
Support Care Cancer; 2000 May; 8(3):229-32. PubMed ID: 10789965
[TBL] [Abstract][Full Text] [Related]
44. Chemotherapy-induced nausea and vomiting. Easing patients' fear and discomfort with effective antiemetic regimens.
Bilgrami S; Fallon BG
Postgrad Med; 1993 Oct; 94(5):55-8, 62-4. PubMed ID: 8415336
[TBL] [Abstract][Full Text] [Related]
45. Prevention of cisplatin-induced acute and delayed emesis by the selective neurokinin-1 antagonists, L-758,298 and MK-869.
Van Belle S; Lichinitser MR; Navari RM; Garin AM; Decramer ML; Riviere A; Thant M; Brestan E; Bui B; Eldridge K; De Smet M; Michiels N; Reinhardt RR; Carides AD; Evans JK; Gertz BJ
Cancer; 2002 Jun; 94(11):3032-41. PubMed ID: 12115394
[TBL] [Abstract][Full Text] [Related]
46. Review of the efficacy of aprepitant for the prevention of chemotherapy-induced nausea and vomiting in a range of tumor types.
Aapro MS; Schmoll HJ; Jahn F; Carides AD; Webb RT
Cancer Treat Rev; 2013 Feb; 39(1):113-7. PubMed ID: 23062719
[TBL] [Abstract][Full Text] [Related]
47. Antiemetic effect of ondansetron and dexamethasone in gynecologic malignant patients receiving chemotherapy.
Pradermdee P; Manusirivithaya S; Tangjitgamol S; Thavaramara T; Sukwattana P
J Med Assoc Thai; 2006 Oct; 89 Suppl 4():S29-36. PubMed ID: 17725140
[TBL] [Abstract][Full Text] [Related]
48. Optimal combination therapy with Navoban (tropisetron) in patients with incomplete control of chemotherapy-induced nausea and vomiting. The Belgian Navoban Group.
Van Belle SJ; Cocquyt VF; Bleiberg H; Canon JL; Buyse M; Hulstaert F; De Witte M; De Keyser P; Westelinck K
Anticancer Drugs; 1995 Feb; 6 Suppl 1():22-30. PubMed ID: 7749166
[TBL] [Abstract][Full Text] [Related]
49. The control of delayed nausea.
Roila F; Ballatori E
Ann Oncol; 1997 Jun; 8(6):615-6. PubMed ID: 9261534
[No Abstract] [Full Text] [Related]
50. Beyond current aprepitant evidence: room for improvement on dose selection and chemotherapy-induced nausea and vomiting risk factors.
Okumura LM
Support Care Cancer; 2016 Mar; 24(3):1009-10. PubMed ID: 26660150
[No Abstract] [Full Text] [Related]
51. Cost-effectiveness and quality of life evaluation of ondansetron and metoclopramide for moderately emetogenic chemotherapy regimens in breast cancer.
Lachaine J; Laurier C; Langleben A; Vaillant L
Crit Rev Oncol Hematol; 1999 Nov; 32(2):105-12. PubMed ID: 10612010
[No Abstract] [Full Text] [Related]
52. Chemotherapy-induced nausea and vomiting: strategies for prevention and treatment.
Schwartzberg LS
Clin Adv Hematol Oncol; 2017 Dec; 15(12):906-913. PubMed ID: 29315282
[No Abstract] [Full Text] [Related]
53. Chemotherapy-induced nausea and vomiting: ESMO clinical recommendations for prophylaxis.
Herrstedt J; Roila F;
Ann Oncol; 2008 May; 19 Suppl 2():ii110-2. PubMed ID: 18456745
[No Abstract] [Full Text] [Related]
54. Cipropride in preventing nausea and vomiting induced by severely emetic cytostatic agents.
Serrou B; Cupissol D; Rosenfeld C; Metz R; Coquelin JP; Sauvanet JP
J Int Med Res; 1981; 9(5):390-1. PubMed ID: 7197651
[No Abstract] [Full Text] [Related]
55. ESMO Recommendations for prophylaxis of chemotherapy-induced nausea and vomiting (NV).
ESMO.
Ann Oncol; 2001 Aug; 12(8):1059-60. PubMed ID: 11583185
[No Abstract] [Full Text] [Related]
56. [Use of navoban for nausea and vomiting caused by chemotherapy for malignant tumors].
Seliuzhitskiĭ IV; Temerin KA; Feofanov VP
Vopr Onkol; 1994; 40(4-6):225-7. PubMed ID: 7785250
[TBL] [Abstract][Full Text] [Related]
57. Prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: guideline update and results of the Perugia consensus conference.
Roila F; Herrstedt J; Gralla RJ; Tonato M
Support Care Cancer; 2011 Mar; 19 Suppl 1():S63-5. PubMed ID: 21188425
[No Abstract] [Full Text] [Related]
58. Dronabinol and nabilone ease cancer chemotherapy.
Manzo M
Nursing; 1988 Aug; 18(8):81. PubMed ID: 2839807
[No Abstract] [Full Text] [Related]
59. Nausea and vomiting.
O'Brien C
Can Fam Physician; 2008 Jun; 54(6):861-3. PubMed ID: 18556493
[No Abstract] [Full Text] [Related]
60. [Rational and methods of using antiemetics in the treatment of colorectal cancer].
Roila F
Tumori; 2001; 87(1 Suppl 1):S41-2. PubMed ID: 11300021
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
